Astal Laboratories

Astal Laboratories

86.25
+3.24
(3.90%)
ann
There are new updates from the company1 day ago
Viewcross
right
Market Cap
154.10 Cr
EPS
9.08
PE Ratio
16.52
Dividend Yield
0.00 %
52 Week High
118.00
52 Week Low
66.72
PB Ratio
3.85
Debt to Equity
0.23
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
positive
Astal Laboratories Limited has scheduled a Board of Directors meeting on October 9, 2025, to consider several key matters. The agenda includes increasing the company's authorized share capital, issuing equity shares or convertible warrants on a preferential basis, and making a final decision on acquiring 100% equity shares of Sriven Pharmachem India Private Limited. The board will also approve the notice for an Extraordinary General Meeting and fix its schedule, along with appointing a scrutinizer for the e-voting process. The company has implemented a trading window closure from October 1, 2025, until 48 hours after declaring unaudited financial results for the quarter ended September 30, 2025, affecting all directors, officers, designated persons and their immediate relatives.
positive
Astal Laboratories Reports Strong Q1 Results, Approves Rs 500 Crore Investment Limit IncreaseAug 12, 2025
Astal Laboratories Limited reported quarterly results for the period ended June 30, 2025, showing revenue from operations of Rs 2,532.66 lakhs compared to Rs 1,314.57 lakhs in the corresponding quarter of the previous year. Net profit increased to Rs 208.96 lakhs from Rs 168.91 lakhs year-on-year. The Board approved several key decisions including the 32nd Annual General Meeting scheduled for September 12, 2025, through video conferencing. The company received shareholder approval recommendations to increase investment limits to Rs 500 crore under various sections of the Companies Act, 2013, including investments, guarantees, loans, and borrowing powers. Additionally, the company allotted 939,930 equity shares at Rs 40 per share upon conversion of warrants, raising Rs 28.20 crore from 11 strategic investors. This increased the paid-up equity capital from Rs 98.30 crore to Rs 107.70 crore. The company operates in manufacturing and trading of active pharmaceutical ingredients.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
174.85
#1 27,949.80
397.39
551.40
55,040.00
70
72.10
37.44
279.85
21,878.00
19.32
#1 99,561.70
11.11
#1 1,821
7.37
55.31
69.63
10,444.50
148.13
262.80
28.63
87
35.47
48.09
377.00
3,724.20
85.21
299.41
#1 8,85,900.00
20
#1 1,157.89
60.58
522.95
3,681.60
16.93
387.50
-25.38
407
7.63
46.80
165.78
2,960.10
55.74
262.20
79.10
23
307.14
56.55
575.25
2,085.90
45.26
89.60
6,408.33
42
74.07
59.51
146.34
1,903.60
38.24
312.50
136.92
40
208.70
46.32
41.78
1,402.80
487.22
81.30
15.16
3
0.00
28.03
36,500.00
1,121.90
#1 10.27
67.60
-16.34
115
-19.54
42.74
Forecast
Actual
Growth Rate
Revenue Growth
171.73 %
Net Income Growth
1,012.50 %
Cash Flow Change
-124.37 %
ROE
638.10 %
ROCE
645.59 %
EBITDA Margin (Avg.)
321.22 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
0
0
0
0
0
0
0
0
4
24
64
77
Expenses
0
0
0
0
0
0
0
0
4
23
52
63
EBITDA
0
0
0
0
-0
0
0
0
0
1
13
14
Operating Profit %
0 %
0 %
0 %
0 %
0 %
0 %
12 %
0 %
-4 %
5 %
20 %
19 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
1
1
Profit Before Tax
0
0
0
0
-0
0
0
0
0
1
12
12
Tax
-0
0
0
0
0
0
0
0
0
0
3
3
Net Profit
0
0
0
0
-0
0
0
0
0
1
9
9
EPS in ₹
0.46
0.02
0.01
-0.02
-0.21
-0.07
0.02
-0.04
0.04
1.55
9.08
9.50

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
5
5
5
5
5
5
5
5
10
37
63
Fixed Assets
0
0
0
0
0
0
0
0
0
1
11
Current Assets
5
5
5
5
5
5
0
0
6
27
46
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
5
5
5
5
5
5
5
5
10
36
52
Total Liabilities
5
5
5
5
5
5
5
5
10
37
63
Current Liabilities
0
0
0
0
0
0
0
0
5
13
27
Non Current Liabilities
0
0
0
0
0
0
0
0
0
0
1
Total Equity
5
5
5
5
5
5
5
5
5
23
36
Reserve & Surplus
1
1
1
1
1
1
1
1
1
14
22
Share Capital
4
4
4
4
4
4
4
4
4
10
10

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
0
0
0
0
0
0
0
6
-17
Investing Activities
0
0
0
0
0
0
0
0
2
-6
-8
Operating Activities
-0
-0
-0
-0
-0
-0
-0
-0
-1
-6
-13
Financing Activities
0
0
0
0
0
0
0
0
0
18
3

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Oct 2023
Dec 2023
Feb 2024
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
66.94 %
66.94 %
66.94 %
66.94 %
66.81 %
66.81 %
68.18 %
68.18 %
68.18 %
61.13 %
55.72 %
44.97 %
39.79 %
19.93 %
19.93 %
19.93 %
19.93 %
19.93 %
19.93 %
19.93 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
30.47 %
30.46 %
30.53 %
30.31 %
30.62 %
29.09 %
28.71 %
28.73 %
28.95 %
35.72 %
41.87 %
50.14 %
55.29 %
73.53 %
73.53 %
73.49 %
73.42 %
73.04 %
73.80 %
73.42 %
Others
2.60 %
2.60 %
2.54 %
2.76 %
2.57 %
4.10 %
3.11 %
3.09 %
2.88 %
3.14 %
2.40 %
4.89 %
4.92 %
6.53 %
6.54 %
6.58 %
6.65 %
7.03 %
6.26 %
6.65 %
No of Share Holders
0
1,147
1,148
1,159
1,232
1,262
1,219
1,188
1,163
1,156
1,169
1,193
1,185
1,252
1,241
1,242
1,629
1,925
2,302
2,721

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
19 Dec 2023 CHANGE OF NAME Change Of Name
NA
19 Dec 2023 35.33 35.33
05 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
05 Aug 2024 66.52 90.94
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2024 97.15 94.10
27 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 Jan 2025 73.36 84.19
19 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 May 2025 78.30 84.88
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2025 89.66 95.24
12 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
12 Sept 2025 95.24 82.00

Announcements

Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.1 day ago
Closure of Trading Window4 days ago
Shareholders Meeting- AGM Voting ResultsSep 13, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 13, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 21, 2025
Intimation Of Issuance Of Letter To Shareholders Under Regulation 36 (1)(B) Of SEBI (LODR) Regulations 2025.Aug 18, 2025
Reg. 34 (1) Annual Report.Aug 18, 2025
Shareholders Meeting- AGM On September 12 2025.Aug 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Intimation Of AGM Remote E-Voting Period Cut-Off Date & Book Closure For AGMAug 12, 2025
Corporate Action- Fixes Book Closure For AGM.Aug 12, 2025
Announcement under Regulation 30 (LODR)-AllotmentAug 12, 2025
Results- Financial Results For The Quarter June 30 2025Aug 12, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 12Th August 2025.Aug 12, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday 12Th August 2025.Aug 06, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2025
Closure of Trading WindowJun 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2025
Intimation Of Appointment Of Secretarial AuditorMay 19, 2025
Results- Financial Results For March 31 2025.May 19, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 19Th May 2025May 19, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Monday 19Th May 2025 Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.May 13, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceApr 23, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 23, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateApr 06, 2025
Closure of Trading WindowMar 26, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateMar 26, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 31, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJan 31, 2025
Intimation Of Change In The Address Of Keeping & Maintaining Books Of Accounts At A Place Other Than The Registered Office Of The Company.Jan 28, 2025
Announcement under Regulation 30 (LODR)-Change in Corporate Office AddressJan 28, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 28, 2025
Integrated Filing (Financial)Jan 27, 2025
Statement Of Deviation & VariationJan 27, 2025
Results- Financial Results For The Quarter Ended December 31 2024.Jan 27, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 27Th January 2025.Jan 27, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 27Th January 2025.Jan 27, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJan 21, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Monday January 27 2025Jan 21, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 15, 2025
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressDec 23, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateDec 23, 2024
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotDec 23, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportDec 23, 2024
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011Dec 02, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Dec 02, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Nov 29, 2024
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011Nov 29, 2024

Technical Indicators

RSI(14)
Neutral
57.49
ATR(14)
Volatile
4.05
STOCH(9,6)
Neutral
48.40
STOCH RSI(14)
Neutral
55.66
MACD(12,26)
Bullish
0.44
ADX(14)
Weak Trend
19.54
UO(9)
Bearish
40.83
ROC(12)
Uptrend And Accelerating
3.69
WillR(14)
Neutral
-43.32